CD8A and neoplasm: Retrospective analysis showed that patients with increased tumor-infiltrating CD8+ lymphocytes (TILs) within advanced UC (pT2, pT3, or pT4) have better disease-free survival and OS than patients with similar-staged UC and fewer intra-tumoral CD8+ TILs, suggesting that this lymphocyte infiltration is associated with better outcome [13,14].